Correction: Dal Monte et al. A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma. Int. J. Mol. Sci. 2020, 21, 9267

Key Points

• The research aims to evaluate the effects of topical melatoninergic compounds on blood pressure and nerve protection in a hypertensive glaucoma model.
• Utilized a rat model of hypertensive glaucoma.
• Administered a topical formulation containing melatoninergic compounds.
• Measured blood pressure and assessed neuroprotective effects using standard evaluation methods.
• The formulation significantly reduced blood pressure in the hypertensive model.
• Demonstrated neuroprotective effects on retinal ganglion cells.
• Effects suggest a potential new treatment approach for hypertensive glaucoma.